Selected article for: "host immune response and proinflammatory cytokine"

Author: Liu, Yangli; Tan, Weiping; Chen, Haihong; Zhu, Ying; Wan, Li; Jiang, Ke; Guo, Yubiao; Tang, Kejing; Xie, Canmao; Yi, Hui; Kuang, Yukun; Luo, Yifeng
Title: Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19
  • Cord-id: 3anqsvog
  • Document date: 2021_1_18
  • ID: 3anqsvog
    Snippet: BACKGROUND: The lack of knowledge regarding the pathogenesis and host immune response during SARS-CoV-2 infection has limited the development of effective treatments. Thus, we longitudinally investigated the dynamic changes in peripheral blood lymphocyte subsets and parallel changes in cytokine levels in COVID-19 patients with different disease severities to further address disease pathogenesis. METHODS: A total of 67 patients (10 moderate, 38 severe and 19 critical cases) with COVID-19 admitted
    Document: BACKGROUND: The lack of knowledge regarding the pathogenesis and host immune response during SARS-CoV-2 infection has limited the development of effective treatments. Thus, we longitudinally investigated the dynamic changes in peripheral blood lymphocyte subsets and parallel changes in cytokine levels in COVID-19 patients with different disease severities to further address disease pathogenesis. METHODS: A total of 67 patients (10 moderate, 38 severe and 19 critical cases) with COVID-19 admitted to a tertiary care hospital in Wuhan from February 8th to April 6th, 2020 were retrospectively studied. Dynamic data of lymphocyte subsets and inflammatory cytokines were collected. RESULTS: On admission, compared with moderate cases, severe and critical cases showed significantly decreased levels of total lymphocytes, T lymphocytes, CD4(+) T cells, CD8(+) T cells, B cells and NK cells. IL-6 and IL-10 were significantly higher in the critical group. During the following hospitalization period, most of the lymphocyte subsets in the critical group began to recover to levels comparable to those in the severe group from the fourth week after illness onset, except for NK cells, which recovered after the sixth week. A sustained decrease in the lymphocyte subsets and an increase in IL-6 and IL-10 were observed in the nonsurvivors until death. There was a strong negative correlation between IL-6 and IL-10 and total lymphocytes, T lymphocytes, CD4(+) T cells, CD8(+) T cells and NK cells. CONCLUSIONS: A sustained decrease in lymphocyte subsets, especially CD4(+) T cells and NK cells, interacting with proinflammatory cytokine storms was associated with severe disease and poor prognosis in COVID-19.

    Search related documents:
    Co phrase search for related documents
    • absolute count and lymph spleen: 1
    • acute ards respiratory distress syndrome and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ards respiratory distress syndrome and lymph spleen: 1, 2
    • acute respiratory syndrome coronavirus and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome coronavirus and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome coronavirus and lymph spleen: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute respiratory syndrome coronavirus and lymph spleen node: 1, 2, 3
    • acute respiratory syndrome coronavirus and lymphocyte activation: 1, 2, 3, 4, 5, 6
    • adaptive nk innate and lymphocyte activation: 1
    • admission day and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • admission day and lung tissue: 1, 2
    • admission day and lymphocyte activation: 1, 2
    • admission level and lung disease: 1, 2, 3, 4, 5, 6
    • lung disease and lymph spleen: 1
    • lung disease and lymph spleen node: 1
    • lung tissue and lymph spleen: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • lung tissue and lymph spleen node: 1, 2